5.5. Analysis.
Comparison 5 Fluvoxamine versus newer ADs, Outcome 5 Depression scale ‐ Endpoint score: low=good (early phase) ‐ missing SDs or skewed data.
Depression scale ‐ Endpoint score: low=good (early phase) ‐ missing SDs or skewed data | ||||||||
---|---|---|---|---|---|---|---|---|
Study | Depression scale | Fluvoxamine; mean | SD | n | comparator; mean | SD | n | Note |
vs Mirtazapine | ||||||||
Schoemaker 2002 | HRSD‐17 | 16.5 | missing | 203 | 14.8 | missing | 199 | |
vs Moclobemide | ||||||||
Bocksberger 1993 | MADRS | 31.5 | 9.8 | 19 | 20.0 | 10.8 | 19 | skewed. |